News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

27

2026

-

04

Deepening Government-Enterprise Cooperation: Yi’nan County Party Secretary Hou Zhanfu and Delegation Conduct Research Visit to Keyuan Pharmaceutical and Linuo Pharmaceutical

Classification:

Corporate News


       4 month 27 On [date], Hou Zhanfu, Secretary of the Yinan County Party Committee, and Ren Lijun, a member of the County Government Party Leadership Group and Deputy County Mayor, led a delegation comprising heads of the County Health Commission, the County Bureau of Industry and Information Technology, the County Finance and Investment Group, and other relevant departments to visit Keyuan Pharmaceutical. & Lilun Pharmaceutical conducted an on-site inspection of the company’s development and held discussions on deepening government-enterprise cooperation and advancing the high-quality development of the pharmaceutical and health industry.

Gao Yuankun, Chairman and President of Linuo Group, Keyuan Pharmaceutical & Li Hongfu, Chairman of Linuo Pharmaceutical, Wei Zhiguo, President, and other leaders of the group and its subsidiaries extended a warm welcome and accompanied the delegation on the inspection tour.

Secretary Hou Zhanfu and his delegation visited the R&D center for injectable formulations, the production workshops, the intelligent quality-control center, and other facilities, gaining a detailed understanding of the company’s operations in areas such as chemical API and formulation R&D, manufacturing, quality control, market deployment, and industrial synergy. They also commended the company’s deep commitment to the chronic-disease pharmaceutical sector and its efforts to build “Active Pharmaceutical Ingredient” + High praise was given to the integrated industrial ecosystem for pharmaceutical preparations, as well as to the achievements made in technological innovation, intelligent manufacturing, and green production.

At the symposium, Chairman Gao Yuankun extended a warm welcome to Secretary Hou Zhanfu and his delegation, and expressed sincere gratitude for the longstanding care and support provided by the Yinan County Party Committee and County Government. Chairman Li Hongfu then gave a detailed report on Keyuan Pharmaceutical. & Lino Pharmaceutical’s production and operations, R&D innovation, talent development, and future growth plans. He stated that the company will continue to strengthen its core competitive advantage in “integrated API–formulation” capabilities, consistently launch high-quality pharmaceutical products, and actively explore deeper collaboration with Yinan County in areas such as industrial supporting infrastructure, project implementation, and industry–university–research partnerships, thereby achieving mutually beneficial outcomes for both government and enterprise.

Secretary Hou Zhanfu on Keyuan Pharmaceutical & The development achievements and clear development plan of Linuo Pharmaceutical have been fully affirmed. He pointed out that the pharmaceutical and health industry is a strategic emerging industry that Yinan County is prioritizing for cultivation, and the county is currently advancing the construction of the Pharmaceutical and Health Industry Park to high standards, with the aim of building a modern pharmaceutical industry cluster integrating R&D, production, and sales. Keyuan Pharmaceutical & As a leading player in China’s chemical API sector, Linuo Pharmaceutical boasts strong technical capabilities, a comprehensive product portfolio, and promising growth prospects. Its strategic initiatives in compliance-driven innovation, business optimization, and industrial integration are highly aligned with the development direction of the pharmaceutical industry in Yinan County. It is hoped that both parties will take this visit as an opportunity to further enhance communication and coordination, focusing on key areas such as industrial tourism, health-oriented food products, and market promotion, thereby jointly ushering in a new chapter of government–enterprise cooperation and mutually beneficial development.

The two sides also engaged in in-depth exchanges on specific matters such as industrial policies, project cooperation, factor assurance, and brand development, reaching broad consensus.

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.